Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A diagnostic scale for Alzheimer’s disease based on cerebrospinal fluid biomarker profiles

26 Jun 2014

Abstract excerpt

INTRODUCTION: The relevance of the cerebrospinal fluid (CSF) biomarkers for the diagnosis of Alzheimer's disease (AD) and related disorders is clearly established. However, the question remains on how to use these data, which are often heterogeneous (not all biomarkers being pathologic). The objective of this study is to propose to physicians in memory clinics a biologic scale of probabilities that the patient...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer's disease research and treatments
Share to Dementia and Cognitive Impairment Research
Share to Intracerebral and Subarachnoid Hemorrhage Research

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 25478015
DOI: 10.1186/alzrt267

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A diagnostic scale for Alzheimer’s disease based on cerebrospinal fluid biomarker profilesPMID 25478015Read ↗

Clinical diagnosis of Alzheimer's disease: recommendations of the International Working Group.Semantic proximity Read ↗

Promising clinical tools for specific Alzheimer disease diagnosis from plasma pTau217 and ApoE genotype in a cognitive disorder unitSemantic proximity Read ↗

Disentangling relationships between Alzheimer's disease plasma biomarkers and established biomarkers in patients of tertiary memory clinicsSemantic proximity Read ↗

The past and the future of Alzheimer's disease CSF biomarkers—a journey toward validated biochemical tests covering the whole spectrum of molecular eventsSemantic proximity Read ↗

The Impact of Cerebrospinal Fluid Biomarkers on the Diagnosis of Alzheimer’s DiseaseSemantic proximity Read ↗

Biomarker-based staging of Alzheimer disease: rationale and clinical applicationsSemantic proximity Read ↗

Development and clinical validation of blood-based multibiomarker models for the evaluation of brain amyloid pathologySemantic proximity Read ↗

Soluble Amyloid-Beta Isoforms Predict Downstream Alzheimer’s Disease PathologySemantic proximity Read ↗

Identification of a simple and novel cut-point based CSF and MRI signature for predicting Alzheimer’s disease progression that reinforces the 2018 NIA-AA research frameworkSemantic proximity Read ↗

A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkersSemantic proximity Read ↗

Emerging Biomarkers for Early Detection of Alzheimer’s Disease: A Systematic ReviewSemantic proximity Read ↗

Comprehensive evaluation of AT(N) imaging biomarkers for predicting cognitionSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.